News

Med Schools Just Say No to Pharmaceutical Gifts


 

SACRAMENTO — Another medical school has joined what could be a growing movement to ban faculty and residents from accepting any gifts whatsoever from drug company representatives.

The University of California, Davis, Health System decided in late 2006 to forbid its medical staff to accept any gifts from drug salesmen, including drug samples, pens, mugs, and meals, however small they might be. Earlier, the school had banned drug company representatives from walking into the clinical areas on a preceptorship.

By taking this action, the school joins institutions such as Yale University, which implemented its policy in 2005, the University of Pennsylvania, which did so in July 2006, and Stanford University, which implemented its policy in October 2006. At UC Davis, the policy goes into effect in July.

The new policy “picks off the low-lying fruit” in an attempt to create a greater distance between clinical practice and the pharmaceutical industry, said Dr. Timothy E. Albertson, the university system's executive director of clinical care.

The efforts at UC Davis and the other academic medical centers were spurred in part by an article in the Journal of the American Medical Association (2006;295:429–33).

The article noted that many authoritative bodies, including the Pharmaceutical Research and Manufacturers of America and government agencies, have made attempts to curtail practices that constitute a conflict of interest for physicians. But the article also said those actions have largely failed to change the climate. Thus, the 11 authors of the paper urged academic medical centers to take the lead.

Academic medical centers need to adopt such policies because the medical profession looks to them for leadership, and because academic medical centers shape the ethics of the profession, the proposal said.

According to IMS Health, a pharmaceutical information and consulting company, drug companies spent $27 billion on product promotion in 2004, of which $16 billion was for free drug samples and $7.3 billion, including gifts and meals, went to sales representative contacts.

The pharmaceutical industry, which adopted strict guidelines on gift giving in 2002, says that limiting the practices and access of their sales representatives will deprive physicians of the best expertise on their medicines.

But gifts, however insignificant, establish an unspoken quid pro quo between physicians and pharmaceutical companies. If gifts did not serve this purpose, companies would not give them, the JAMA authors say. They note that the research bears this out.

According to a 2003 survey of more than 1,000 third-year medical students, an average third-year student receives one gift or attends one company-sponsored activity a week (JAMA 2005;294:1034–42). That is precisely the point of the no-gift policies proposed by the JAMA article, said one of its authors, Dr. Jerome P. Kassirer, former editor-in-chief of the New England Journal of Medicine.

“These meals and gifts give residents and trainees the idea that pharmaceutical largesse is all right and the way things work, but it taints the profession,” Dr. Kassirer said in an interview. “I think the academic medical centers needed a little nudge.”

At the academic medical centers, free meals appear to be the big issue impeding acceptance of the policies. The free meals allow physicians to attend midday meetings they otherwise would not have time to attend, and they are a big ticket item.

At the UC Davis Cancer Center alone, it is estimated that companies spend about $70,000 on free lunches a year. The center will now pick up those costs, and other departments may have to do the same.

At the University of Pennsylvania Health System, the adoption of its policy caused some grumbling at first, along with the loss of some legitimate educational programs that were sponsored. For the most part, however, physicians and other staff members have adjusted, said Dr. Patrick J. Brennan, the chief medical officer of the university health system.

Recommended Reading

Consensus Elusive on Financial Disclosure Issues
MDedge Pediatrics
AAP Releases Phone Care Toolkit, Policy Statement
MDedge Pediatrics
Survey Finds Pediatricians in U.S. Satisfied With Well-Child System
MDedge Pediatrics
To Improve, Put Practice Under the Microscope : The Bright Futures and Practicing Safety projects are cited, along with the value of an outside facilitator.
MDedge Pediatrics
Going From Pediatric to Adult Care for Diabetes Is a Problem
MDedge Pediatrics
Obesity Costs $49 Billion for Every 4 Million Born in U.S.
MDedge Pediatrics
Performance Measures to Focus on Quality of Care
MDedge Pediatrics
Policy & Practice
MDedge Pediatrics
Standards Aim to Enable EHRs, Retire Clipboards
MDedge Pediatrics
What Do You Want to Know?
MDedge Pediatrics